Services on Demand
- Cited by SciELO
- Access statistics
Print version ISSN 1415-4757
Genet. Mol. Biol. vol.30 no.3 São Paulo 2007
Karen C.M. Moraes1; Carol J. Wilusz; Jeffrey Wilusz
Department of Microbiology, Immunology and Pathology, Colorado State University, Campus Delivery, Fort Collins, CO, USA
Several mRNAs have been shown to exhibit distinct patterns of poly(A) shortening prior to their decay in vivo. In this study, we show that individual transcripts also demonstrate distinct patterns of deadenylation in in vitro systems derived from HeLa and Jurkat T cell cytoplasmic extracts. The major patterns observed were slow/synchronous and fast/asynchronous poly(A) tail shortening. For all RNA substrates tested, PARN was shown to be the enzyme responsible for the deadenylation patterns that were observed. Sequences in the 3' untranslated regions influenced the deadenylation pattern. Using a fragment of the 3'UTR of the c-fos mRNA as a model, the interaction of CUG-BP, the human homolog of EDEN-BP - a protein previously implicated in regulated deadenylation in Xenopus oocytes - was shown to be associated with changes in PARN-mediated deadenylation patterns. Our results suggest that association of CUG-BP with 3'UTR sequences can modulate the activity of the PARN deadenylase in mammalian cell extracts.
Key words: mRNA decay, deadenylation, mRNA stability, 3'UTR, CUG-BP.
The stability of an mRNA plays an important role in the regulation of gene expression (Wilusz and Wilusz, 2004; Audic and Hartley, 2004; Garcia-Martinez et al., 2004). The major pathways of mRNA decay in eukaryotic cells initiate with the shortening of the 3' poly(A) tail (Meyer et al., 2004; Wilson and Treisman, 1988). Following deadenylation, the body of the transcript is effectively degraded by either decapping/5'-to-3'exonuclease action or by a complex of 3'-to-5' exonucleases (Butler, 2002; Coller and Parker 2004). Elements that regulate the efficiency of mRNA turnover in response to growth, differentiation, environmental stimuli, etc. are often, but not exclusively (e.g. Lemm and Ross, 2002; Hughes and Brady, 2005), found in the 3' untranslated region (UTR) of the transcript (Chen et al., 1995). Among them, the best described is the AU-rich element which plays a role in regulating the level of a wide variety of transcripts in multiple eukaryotes (Chen and Shyu, 1995; Guhaniyogi and Brewer, 2001; Raghaven et al., 2004).
Deadenylation is an attractive mechanism for regulation since it is the first step in the majority of mRNA decay. Numerous candidate deadenylases have been identified to date in mammalian cells. PARN (Poly(A)-specific 3'-to-5' exoRiboNuclease), whose activity is readily demonstrable in extracts (Korner and Wahle, 1997; Korner et al. 1998), exhibits an interesting interaction with the 5' cap of transcripts that influences its processivity (Dehlin et al., 2000; Gao et al., 2000; Martinez et al., 2001). In addition, PARN co-purifies with several components of the mRNA decay machinery (Lejeune et al., 2003). At least six homologs of CCR4, a major yeast deadenylase, can be identified in mammalian genomes (Dupressoir et al., 2001). Vertebrate CCR4 isoforms have been shown to co-purify with other mRNA decay components (Collart and Timmers, 2004; Cougot et al., 2004) and one, nocturnin, shows an interesting pattern of gene expression related to circadian rhythms (Baggs and Green, 2003). In addition, Shyu and co-workers recently targeted a human CCR4 isoform with siRNA and demonstrated an effect on the overall decay rate of a reporter mRNA containing a coding region instability element (Yamashita et al. 2005). POP2/CAF1 constitutes the third class of candidate deadenylases in human cells. These are found in complex with CCR4 and a mammalian isoform has been shown to possess poly(A) tail shortening activity in vitro (Clark et al., 2004; Viswanathan et al., 2004). Finally, a human homolog of the yeast Pan2/3 deadenylase, which plays a role in poly(A) tail remodeling/length control in the nucleus (Brown and Sachs, 1998), has also recently been described (Dunn et al., 2005; Uchida et al., 2004). Each of these deadenylases is likely to play some role in mRNA metabolism. It will be very important, therefore, to determine the relative roles played by each of these enzymes and assess how the cell regulates their activity.
Relatively little is known about what regulates deadenylase activity in mammalian cells. As mentioned above, PARN interaction with the 5' cap of a transcript stimulates the processivity of poly(A) tail shortening (Dehlin et al., 2000; Gao et al., 2000; Martinez et al., 2001). The availability of the 5' cap, therefore, presents an attractive means of networking mRNA decay and translation. In addition to cap-binding factors, several other proteins have been shown to influence deadenylation (Gherzi et al., 2004; Lai et al., 2003; Tran et al., 2004). Notably, EDEN-BP (Embryo Deadenylation Element-Binding Protein) interacts with a UR-rich motif in the 3'UTR of Xenopus mRNAs and triggers their deadenylation, perhaps by PARN, in developing embryos (Bonnet-Corven et al., 2002; Paillard et al., 1998; Takahashi et al., 2000). EDEN-BP, therefore, plays a vital role in the dynamics of gene expression patterns that are observed after oocyte fertilization (Gautier-Courteille et al., 2004). Homologs to EDEN-BP can be identified in numerous eukaryotes including humans, mice, zebrafish, Drosophila and C. elegans, suggesting that it likely plays a key role in somitic gene expression throughout evolution (Delaunay et al., 2004). The human homolog, CUG-BP (CUG triplet repeat Binding Protein), was first identified as a protein that can interact with a triplet repeat expansion observed in a type of myotonic dystrophy (Timchenko et al., 1996). CUG-BP is localized to both the nucleus and the cytoplasm (Mukhopadhyay et al., 2003; Roberts et at., 1997) and can functionally replace EDEN-BP to promote deadenylation in Xenopus embryo extracts (Paillard et al., 2003). Furthermore, the human c-jun mRNA can be rapidly deadenylated by an EDEN-BP specific pathway upon injection into Xenopus embryos (Paillard et al., 2002). This conservation of key sequence elements and protein domains, therefore, makes it very likely that CUG-BP regulates poly(A) tail shortening in mammalian cells. Consistent with this prediction, we have recently observed that CUG-BP interacts directly with the PARN deadenylase in human cell extracts and can stimulate poly(A) shortening by this enzyme (Moraes et al., 2006).
We have previously developed an in vitro assay using cytoplasmic S100 extracts that faithfully reproduces numerous in vivo aspects of mRNA decay (Ford et al., 1999; Gao et al., 2001; Mukherjee et al., 2002). By testing model RNA substrates, deadenylation in HeLa cytoplasmic extracts was shown to be predominantly if not exclusively performed by PARN and could be significantly stimulated by the presence of an AU-rich element derived from the TNFa mRNA (Ford et al., 1999; Gao et al. 2000). Whether PARN is the major deadenylase in other cell extracts, how its activity is regulated, or whether it may only act on a subset of mRNA substrates, remain to be determined.
In this study we demonstrate that RNA substrates containing various types of AU-rich elements display at least three distinct patterns of deadenylation in HeLa and Jurkat T cell extracts. Furthermore, regulation of poly(A) tail shortening can be demonstrated in T cell extracts in response to activation, suggesting that the in vitro assays replicate several in vivo observations with regard to deadenylation. In vitro deadenylation assays, therefore, are likely to yield relevant clues to the regulation of poly(A) tail shortening. PARN was shown to be the enzyme responsible for the deadenylation observed in vitro in all cases. While AU-rich elements clearly contribute to the deadenylation patterns observed, additional sequences in the 3'UTR were also shown to make a significant contribution. Finally, UV cross-linking analyses with RNA substrates containing variations of the c-Fos 3'UTR clearly implicate CUG-BP as a regulator of PARN activity in mammalian cell extracts. These data suggest a key role for a 3'UTR element and its associated RNA binding protein(s) in regulating deadenylation by the PARN enzyme.
Materials and Methods
Plasmid and DNA template constructions
pGEM-4 plasmids containing 250 bp inserts of the 3'UTR surrounding the ARE elements of representative members of several different subclasses of AU-rich elements were generated by RT-PCR, using RNA prepared from HeLa cells and specific primers for each construction. The primers for cFos-ARE were 5'CCGGAATTCTCTT CAACATCAATGTTCATTGTAATG and 5'CGATCTG CAGT TTATTGACAATGTCTTGGAACAATAAGC; TNFa-ARE were 5'CCGGAATTCTTAGGCCTTCCTC TCTCCAGATGTTTCCAG and 5'CGATCTGCAGACA TGGGAACAGCCTATTGTTCAGCTCC; CYTOR4-ARE were 5'CCGGAATTCGCAGAGAATGAGCTGCAGTC CAG and 5'CCAAGCTTATCTTACAAAAATATCATA CTTGC. The primers for cjun-ARE amplified a 250 bp fragment containing 50 bases upstream and downstream of the ~150 base Class III ARE. The reactions were performed according to the standard conditions described by the supplier (SuperScriptÔ One-Step RT-PCR with Platinum Taq, Invitrogen). To generate pFosARE and pTNFaARE, products from RT-PCR were digested with EcoRI and PstI and cloned into pGEM®-4 (Promega). To generate pCYTOR4ARE, the amplified DNA product was digested with EcoRI and HindIII restriction enzymes and then cloned into pGEM®-4.
DNA fragments used to prepare the ARE deletion constructs cFosDAREwere generated by a two step PCR reaction. In the first step, PCR reactions (performed under standard conditions) were done using the three plasmids described above as templates and the following primers: cFosDARE - sense primer 5'AACAGTTTTCCATGAAA ACGTACCTTGAGGTCTTTTGAC and anti-sense 5'TC AAAAGACCTCAAGGTAGCGTTTTCATGGAAAACTGTT; Final products were cleaved and cloned into pGEM®-4 using the same sites discussed above for the parent constructs.
The pFosARE plasmid described above served as the template to prepare a set of constructs containing defined deletions of 25 base segments. The pFos A construct was constructed using the primer 5'CCGGAATTCCTGATC ATGCATTGTTGAG along with the 3' antisense cFos primer used in the construction of the parent plasmid described above by PCR. The pFos F construct was constructed using the 5' sense primer described above for the parent plasmid along with the primer 5'TCGATCTGCA GAACAATGCTTAAATTTTTCATTC in a PCR reaction. The products were digested with EcoRI and PstI and cloned into pGEM®-4.
The plasmid pFos B was prepared by two rounds of PCR. The first reaction contained the primers 5'AATGTT CATTGTAATGTTAGTTCTGACATTAACAGTTTTC and 5'CGATCTGCAGTTTATTGACAATGTCTTGGAACA ATAAGC. The second reaction was performed using the DNA product from first reaction as a template along with the primers 5'CCGGAATTCTCTTCAACATCAATGTT CATTGTAATG and 5'CGATCTGCAGTTTATTGACA ATGTCTTGGAACAATAAGC. The final product was digested with EcoRI and PstI for cloning into pGem4.
Deletion clones pFosC and pFosE were created by PCR utilizing overlapping primers that lacked specific sequences in a strategy similar to the DARE described above. Reaction 1 contained the primer 5'CCGGAATTCTCT TCAACATCAATGTTCATTGTAATG and a construct-specific antisense primer (pFosC - 5'ATTAAAAACAC AATAAAAATTCAGACCACCTCAACAATGC or pFosE 5'TCGATCTGCAGAACAATGCTTAAATTTTTCATTC). Reaction 2 contained the primer 5'CGATCTGCAG TTTATTGACAATGTCTTGGAACAATAAGC and a construct-specific sense primer (pFosC: 5'ATTGTTGA GGTGGTCTGAATTTTTATTGTGTTTTTAATT or pFosE: 5'ATGTCTTGGAACAATAAGCACTTTCCACATGTCAAAAGAC). PCR products were combined and amplified using the common sense and antisense primers listed above. Reaction products were digested with EcoRI and PstI and cloned into pGEM®-4.
Deletion construct pFos D was prepared by a similar two step PCR reaction as described for the two previous constructs. The unique primers were 5'GATCGTTTAAA AAAATAAAATAAAAATATAAATATCTGAG for Reaction 1 and 5'TGAATTTGAATGAAAAATTTAAGCA TTG for Reaction 2. The DNA product from reaction 1 was digested with Dra I and EcoRI. And the product from reaction 2 was performed was digested with PstI. The restricted DNA fragments were combined and amplified in a standard PCR reaction using 5'CCGGAATTCTCTTCAACATCA ATGTTCATTGTAATG and 5'CGATCTGCAGTTTAT TGACAATGTCTTGGAACAATAAGC. The product from this reaction digested with EcoRI and PstI and cloned into pGEM®-4.
In order to create DNA templates that would yield an RNA with a 60 base poly(A) tail after in vitro transcription, plasmids were linearized using HindIII and sequences encoding a 60 base poly(A) tail were added to DNA using a ligation-PCR approach previously described (Ford et al. 1999).
All clones were sequenced prior to being used for in vitro transcription.
In vitro transcription and RNA purification
RNAs were transcribed in vitro using SP6 RNA polymerase and purified on denaturing acrylamide gels. Transcripts were capped co-transcriptionally by the addition of 5 mM 7me GpppG in the transcription reaction.
Preparation of cell extracts
Cytoplasmic extracts were prepared from HeLa and Jurkat T cells as described previously (Ford and Wilusz, 1999). HeLa cells were grown in spinner culture in 5% horse serum. T cells were grown in 175 cm2 flasks in RPMI 1640 and induced using 15 ng/mL TPA and 1 µg/mL A23187 or treated with control vehicle DMSO solution.
In vitro mRNA decay/ deadenylation assay
Polyadenylated RNAs radiolabeled internally at U-residues were incubated in HeLa S100 cytoplasmic extracts or Jurkat T cell extracts at 30 °C as described previously (Ford and Wilusz, 1999). Reaction products were analyzed on 4% polyacrylamide gels containing 7 M urea.
Hela and Jurkat T cell cytoplasmic extracts were immunodepleted using the same conditions previously described (Gao et al., 2000) using either control rabbit serum or an anti-PARN polyclonal antibody kindly provided by Dr. Michael Wormington. Briefly, immunodepletions were performed using 3 µL of antisera and 1 µL of RNAsin. Immune complexes were precipitated using Protein A sepharose and depleted extracts were used in the in vitro mRNA decay system described above. Western blotting experiments were performed in order to verify PARN immunodepletion of > 95% (data not shown).
UV cross linking/ Immunopreciptation/ Competition assays
UV cross-linking analyses were performed as described (Ford et al., 1999). Cross-linking assays were done in the presence of 25 mM EDTA to inhibit RNA turnover and allow for accurate comparisons between samples. After digestion with RNase A, cross-linked proteins were analyzed on 10% acrylamide gels containing SDS.
For immunoprecipitation analysis following UV cross-linking, 400 µL of Net2 buffer (50 mM Tris [pH 7.6], 75 mM NaCl, 0.05% Nonidet P-40) was added to samples and mixtures were centrifuged for 2 min to remove precipated/aggregated proteins. Pre-cleared samples were incubated at 4 °C with antibodies under gently shaking conditions for 3 h. Antigen-antibody complexes were collected on protein A-positive Staphylococcus aureus cells and washed five times with Net2 buffer. The immunoprecipitated cross-linked proteins were separated on a 10% acrylamide gel containing SDS. Polyclonal antisera specific for CUG-BP were the kind gift of Dr. Maurice Swanson.
Results and Discussion
Different mRNAs have been shown to have distinct deadenylation kinetics in vivo (Chen et al., 1995; Xu et al., 1997). The Class II ARE-containing GM-CSF and TNF-a mRNAs, for example, demonstrate asynchronous cytoplasmic deadenylation which is consistent with processive activity of the poly(A) shortening enzyme. Class I (c-fos) and Class III (c-jun), on the other hand, show synchronous poly(A) shortening, consistent with distributive deadenylation kinetics. Other transcripts bear poly(A) tails that are very stable and refractory to deadenylation. We wished to assess whether we could reproduce deadenylation patterns in cytoplasmic extracts that were consistent with these in vivo observations.
Capped and polyadenylated substrates containing a 250 base fragment of the 3'UTR surrounding the ARE of members of the seven proposed classes of ARE elements (Garneau et al., 2007) were incubated in HeLa cytoplasmic S100 extracts in our in vitro mRNA decay system. As seen in Figure 1A and B, three patterns of deadenylation were observed. The cFos-A60 RNA substrate was deadenylated in a slow and synchronous manner. A similar slow and synchronous pattern was observed with a c-jun-A60 RNA substrate (Figure 1A, bottom right panel). This is very consistent with the kinetics of poly(A) shortening of Class I (c-fos) and Class III (c-jun) ARE-containing transcripts in vivo (Chen et al., 1995; Xu et al., 1997) and suggestive of a distributive mechanism of deadenylation. Just as was observed in vivo (Chen et al., 1995; Xu et al., 1997), the Class IIA ARE containing TNFa-A60 RNA substrate was deadenylated in a fast and asynchronous manner in vitro. This is suggestive of a processive mechanism of poly(A) shortening on this transcript. Finally, RNA substrates such as the Class IIE ARE containing CYTOR4-A60 RNA in Figure 1 exhibited a pattern of no or very little deadenylation in vitro (CYTOR-4 is cytokine receptor related protein-4 (Genbank accession no. AF046059)). We conclude that deadenylation patterns in HeLa cytoplasmic extracts are RNA substrate-dependent and generally fall into three categories - fast/asynchronous, slow/synchronous, and no poly(A) shortening. Furthermore, these appear to faithfully reproduce patterns that have been observed in vivo.
Independent deadenylase enzymes could contribute to the differential deadenylation patterns discussed above. As mentioned above numerous candidate deadenylase enzymes have been identified in mammalian cells including, for example, PARN, CCR4, Caf1/POP2 and Pan2/3 (Fritz et al., 2003). We have previously shown that PARN was the major deadenylase in HeLa cytoplasmic extracts for RNA substrates containing the TNFa ARE and a polylinker-derived transcript (Gao et al., 2000), but had not tested other RNAs. We wished to determine, therefore, whether PARN was the major deadenylase for other RNA substrates or if there were, perhaps, transcript-specific deadenylases that were active in vitro. The role of PARN in the poly(A) shortening of RNA substrates that display slow/synchronous or fast/asynchronous patterns of deadenylation was investigated in HeLa cytoplasmic extracts using an immunodepletion approach. As seen in Figure 1C, while immunodepletion of HeLa extracts with control sera had no or minimal effects, depletion of ~95% of PARN protein (as determined by western blotting (Gao et al., 2000; data not shown) blocked most of the poly(A) shortening observed on either the cFos-A60 or TNFa-A60 RNA substrates. Addition of recombinant PARN protein to extracts immunodepleted with PARN antisera effectively restored deadenylation. Similar observations were made using Jurkat T cell extracts (Figure 1D). The deadenylation of all RNA substrates that we have tested to date is essentially blocked in cytoplasmic extracts that have been immunodepleted of PARN protein or have PARN activity sequestered by the addition of cap analog to the reactions (Gao et al. 2000). We conclude, therefore, that at least in cytoplasmic extracts of HeLa and Jurkat T cells, if not most cells, PARN is the major enzyme responsible for poly(A) shortening. The activity of PARN, therefore, must be regulated to account for the differences in deadenylation patterns that were observed in vitro.
We next wished to test whether deadenylation patterns observed with HeLa cytoplasmic extracts could be reproduced in extracts from other cell types. Furthermore, we wished to assess whether in vitro deadenylation patterns could be altered to reflect regulatory changes that occur in vivo. Jurkat cells, an immortalized T cell line, can be stimulated by phorbol esters to produce IL2 and are widely used to study the molecular responses associated with T cell activation. Jurkat T cells were grown under normal uninduced conditions or activated by the addition of TPA (12-O-tetradecanoylphorbol-13-acetate)/A23187 (a calcium ionophore) and cytoplasmic S100 extracts were prepared. As seen in Figure 2, the patterns of deadenylation of cFos-A60, TNFa-A60 and CYTOR-4-A60 RNA substrates in extracts from untreated T cells were very similar to that observed with HeLa cells. cFos-A60 was deadenylated in a slow synchronous pattern, TNFa-A60 was deadenylated in a fast, asynchronous manner, and the poly(A) tail of the CYTOR-4-A60 RNA substrate was essentially stable. In extracts from TPA-induced T cells, the ARE-containing RNA substrates became extremely stable, and the pattern of any poly(A) shortening that was observed was very slow/synchronous. Deadenylation of a control, polylinker-derived transcript was not altered in extracts from induced Jurkat cells (data not shown). This is consistent with the stabilization of ARE-containing mRNAs that occurs in T cells upon TPA/A23187 treatment (Raghaven et al., 2004). We conclude that deadenylation patterns observed in HeLa cells can be generalized to T cell extracts and perhaps other cell types as well. Furthermore, the regulation of deadenylation that can be observed in vivo upon T cell induction can be reproduced in cytoplasmic extracts. Therefore the study of deadenylation mechanisms in vitro should provide some insight into in vivo phenomena.
Since a fast/asynchronous pattern of deadenylation has been observed on polylinker-derived RNA substrates (Ford et al., 1999; Gao et al., 2000), other aspects of the c-fos 3'UTR must be contributing to the observed slow/synchronous pattern of deadenylation on this RNA substrate. Our next goal was to localize the regions responsible for the observed pattern of poly(A) shortening by PARN on this substrate.
In order to localize additional elements in the cFos RNA substrate that influence its deadenylation pattern, a series of deletion constructs were made that are diagrammed in Figure 3A. As seen in Figure 3, panels B and C, a switch from slow/synchronous to fast/asynchronous deadenylation was clearly observed with deletion variants cFos DB, cFos DC and cFos DE. These represent deletions of blocks of sequence both before and after the ARE element. We conclude that either a large and diffuse 3'UTR element, or multiple regions that interact in some fashion, perhaps through the formation of a secondary structure, significantly influences the deadenylation pattern of the cFos RNA.
We next wished to identify RNA binding proteins that may influence the deadenylation pattern of cFos mRNA. UV cross-linking analyses were performed on the wild type cFos-A60 RNA as well as the six variants outlined in Figure 3A. When radiolabeled cFos-A60 RNA was incubated in HeLa cytoplasmic S100 extracts, multiple cross-linked protein species were observed (Figure 4B, lane cFos). Interestingly, when the data for each of the cFos A-F variant RNAs was analyzed, a protein of ~50kDa was consistently observed to cross-link more effectively to the DB, DC and DE cFos variant transcripts (Figure 4B, compare lanes A-F). The cFos DB, DC and DE variants were precisely the same set of variants that caused the switch in a deadenylation pattern from slow/synchronous to fast/asynchronous (Figure 3B). The cross-linking of this 50 kDa protein, therefore, correlates perfectly with the switch in the pattern of PARN-mediated deadenylation associated with these three variants.
We have recently demonstrated that CUG-BP, a human homolog of the EDEN-BP protein previously implicated in regulated deadenylation in Xenopus embryos (Bonnet-Corven et al., 2002; Paillaird et al., 1998), can interact with PARN and stimulate deadenylation efficiency in HeLa cell extracts (Moraes et al., 2006). Consistent with this observation, antibodies to CUG-BP precipitated the cross-linked 50 kDa protein (Figure 4C). Control sera or unrelated antibodies failed to precipitate the 50 kDa protein (data not shown). As seen in Figure 4C, the amount of cross-linked CUG-BP that was immunoprecipitated from the DB, DC and DE variants was also relatively higher than the other three variants. The ~two fold effect observed in these data was highly reproducible. We conclude, therefore, that an increase in CUG-BP cross-linking with our set of variant cFos-A60 RNA substrates directly correlated with a change in the deadenylation pattern from slow/synchronous to fast/asynchronous. The cFos-A60 3'UTR region contains several UGUR sequences which have been previously implicated in CUB-BP binding (Figure 4A). We hypothesize that the cFos DB, DC and DE deletion variants may juxtapose UGUR sites in the RNA substrate and create a more efficient CUG-BP binding region that results in more effective UV cross-linking and faster deadenylation kinetics. This model is consistent with the recent observation by Cosson et al. (2006) that oligomerization of the CUG-BP homolog EDEN-BP is required for efficient RNA binding and deadenylation in Xenopus.
In summary, the data presented above establish four interesting points concerning the process of deadenylation. First, various patterns of deadenylation can be effectively reproduced in cytoplasmic extracts, providing a valuable technical resource to gain potential mechanistic insights into the process. Second, PARN is the major deadenylase in all tested cytoplasmic extracts and can act on a variety of mRNA substrates - as well as be influenced by cis-acting elements present on the RNA substrate. Third, 3'UTR sequences, including but not limited to AU-rich elements, can regulate PARN deadenylation patterns. Finally, CUG-BP, a close homolog of a known developmental regulator of deadenylation in Xenopus embryos, was identified as a candidate regulator of PARN. Collectively, these observations suggest that PARN may play an important role in regulated deadenylation through functional interactions with 3'UTR elements and binding factors.
Deletion of the ARE in the cFos-A60 substrate in Figure 3B demonstrated that this element was not required for the slow/synchronous pattern of deadenylation observed for this RNA substrate. The ARE, however, may play a role in changing the deadenylation pattern of the transcript to fast/asynchronous that can occur under certain conditions. The deletion of the ARE in the TNFa-A60 RNA substrate resulted in a reproducible change in the pattern of deadenylation from fast/asynchronous to a slower/synchronous one (data not shown). The Class IIA ARE in the TNFa RNA substrate, therefore, does significantly contribute to the deadenylation pattern that is observed in vitro. Surprisingly, deletion of the Class IIE ARE in the CITOR4-A60 RNA substrate failed to activate deadenylation in vitro. In conclusion, while an ARE can clearly contribute to the fast/asynchronous deadenylation pattern as in the case of the TNFa RNA substrate, other sequences in the 3'UTR of the mRNA appear to play a significant role as well in determining the slow/synchronous pattern as well as the repression of poly(A) shortening. Therefore the ARE is only one of several contributing factors to the overall pattern of deadenylation that is observed with individual transcripts.
The model that emerges from these observations suggests that the combination of protein factors or RNA structures that assembles on the 3'UTR of an mRNA dictate how the transcript will associate with the relevant deadenylase. This assembled complex then determines the kinetics of the deadenylation process. The 3'UTR complex, along with perhaps the rate of poly(A) tail shortening, may allow the mRNA to effectively be targeted for storage and subsequent re-adenylation / translation rather than rapidly degraded by an exonucleolytic pathway. The fact that these exonucleolytic pathways also are regulated by an array of protein factors (Garneau et al., 2007) suggests that the deadenylation process may serve as a gatekeeper for several possible fates of the transcript rather than simply acting as the first step in its degradation. Thus, it will be important to fully understand the relationship of deadenylation and 3'UTR complex formation in order to gain a better perspective on this aspect of the post-transcriptional control of gene expression. It is interesting to note that CUGBP2 has in fact recently been implicated in translational silencing of the Cox-2 mRNA in cells following radiation treatment (Mukhopadhyay et al., 2003).
While the data presented in this study clearly support a role for PARN in deadenylation of mammalian mRNAs, they do not exclude a role of one or more of the other candidate deadenylase enzymes that have been identified. Although PARN is highly active and can form complexes with other decay factors, it appears to be non-essential in both fungi and C. elegans (Tucker et al., 2001). CCR4, which has been shown to be a major deadenylase in yeast (Tucker et al., 2001), has also more recently been shown to be the major deadenylase in Drosophila (Temme et al., 2004). Both yeast and Drosophila do, however, lack a good PARN homolog. One interesting explanation for the exquisite stability of the CITOR4-A60 RNA substrate in our study could be that it contains 3'UTR elements that specifically target the transcript for poly(A) tail shortening by an enzyme that is not present or active in the S100 cytoplasmic extracts. In addition to the data that we report here for PARN, CCR4, Caf1 and Pan2/3 activities have been shown to be influenced by 3'UTR structure and/or sequences (Lowell et al., 1992; Chen et al., 2002; Viswanathan et al., 2003), and CCR4 may be targeted by a coding region instability determinant as well (Chang et al., 2004). Therefore internal sequences in the body of the mRNA appear to play a large role in determining the efficiency of shortening of the 3' poly(A) tail once an mRNA has been targeted for turnover.
We wish to thank Drs. Michael Wormington and Maurice Swanson for providing antibody reagents and members of the Wilusz laboratory for critical comments on the manuscript. This work was supported by an AHA Scientist Development Grant (#0130470T) to C.J.W and NIH grant GM072481 to J.W.
Audic Y and Hartley RS (2004) Post-transcriptional regulation in cancer. Biol Cell 96:479-498. [ Links ]
Baggs JE and Green CB (2003) Nocturnin, a deadenylase in Xenopus laevis retina: A mechanism for posttranscriptional control of circadian-related mRNA. Curr Biol 13:189-198. [ Links ]
Bonnet-Corven S, Audic Y, Omilli F and Osborne HB (2002) An analysis of the sequence requirements of EDEN-BP for specific RNA binding. Nucleic Acids Res 30:4667-4674. [ Links ]
Brown CE and Sachs AB (1998) Poly(A) tail length control in Saccharomyces cerevisiae occurs by message-specific deadenylation. Mol Cell Biol 18:6548-6559. [ Links ]
Butler JS (2002) The yin and yang of the exosome. Trends Cell Biol 12:90-96. [ Links ]
Chang TC, Yamashita A, Chen CY, Yamashita Y, Zhu W, Durdan S, Kahvejian A, Sonenberg N and Shyu AB (2004) UNR, a new partner of poly(A)-binding protein, plays a key role in translationally coupled mRNA turnover mediated by the c-fos major coding-region determinant. Genes Dev 18:2010-2023. [ Links ]
Chen J, Chiang YC and Denis CL (2002) CCR4, a 3'-5' poly(A) RNA and ssDNA exonuclease, is the catalytic component of the cytoplasmic deadenylase. EMBO J 21:1414-1426. [ Links ]
Chen CY and Shyu AB (1995) AU-rich elements: Characterization and importance in mRNA degradation. Trends Biochem Sci 20:465-470. [ Links ]
Chen CY, Xu N and Shyu AB (1995) mRNA decay mediated by two distinct AU-rich elements from c-fos and granulocyte-macrophage colony-stimulating factor transcripts: Different deadenylation kinetics and uncoupling from translation. Mol Cell Biol 15:5777-5788. [ Links ]
Clark LB, Viswanathan P, Quigley G, Chiang YC, McMahon JS, Yao G, Chen J, Nelsbach A and Denis CL (2004) Systematic mutagenesis of the leucine-rich repeat (LRR) domain of CCR4 reveals specific sites for binding to CAF1 and a separate critical role for the LRR in CCR4 deadenylase activity. J Biol Chem 279:13616-13623. [ Links ]
Collart MA and Timmers HT (2004) The eukaryotic CCR4-not complex: A regulatory platform integrating mRNA metabolism with cellular signaling pathways? Prog Nucleic Acid Res Mol Biol 77:289-322. [ Links ]
Coller J and Parker R (2004) Eukaryotic mRNA decapping. Annu Rev Biochem 73:861-890. [ Links ]
Cosson B, Gautier-Courteille C, Maniey D, Ait-Ahmed O, Lesimple M, Osborne HB and Paillard L (2006) Oligomerization of EDEN-BP is required for specific mRNA deadenylation and binding. Biol Cell 98:653-665. [ Links ]
Cougot N, Babajko S and Seraphin B (2004) Cytoplasmic foci are sites of mRNA decay in human cells. J Cell Biol 165:31-40. [ Links ]
Dehlin E, Wormington M, Korner CG and Wahle E (2000) Cap-dependent deadenylation of mRNA. EMBO J 19:1079-1086. [ Links ]
Delaunay J, Le Mee G, Ezzeddine N, Labesse G, Terzian C, Capri M and Ait-Ahmed O (2004) The Drosophila Bruno paralogue Bru-3 specifically binds the EDEN translational repression element. Nucleic Acids Res 32:3070-3082. [ Links ]
Dunn EF, Hammell CM, Hodge CA and Cole CN (2005) Yeast poly(A)-binding protein, Pab1, and PAN, a poly(A) nuclease complex recruited by Pab 1, connect mRNA biogenesis to export. Genes Dev 19:90-103. [ Links ]
Dupressoir A, Morel AP, Barbot W, Loireau MP, Corbo L and Heidmann T (2001) Identification of four families of yCCR4- and Mg2+-dependent endonuclease-related proteins in higher eukaryotes, and characterization of orthologs of yCCR4 with a conserved leucine-rich repeat essential for hCAF1/hPOP2 binding. BMC Genomics 2:9. [ Links ]
Ford LP, Watson J, Keene JD and Wilusz J (1999) ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation system. Genes Dev 13:188-201. [ Links ]
Ford LP and Wilusz J (1999) An in vitro system using HeLa cytoplasmic extracts that reproduces regulated mRNA stability. Methods 17:21-27. [ Links ]
Fritz DT, Bergman N, Kilpatrick WJ, Wilusz CJ and Wilusz J (2004) Messenger RNA decay in mammalian cells: The exonuclease perspective. Cell Biochem Biophys 41:265-278. [ Links ]
Gao M, Fritz DT, Ford LP and Wilusz J (2000) Interaction between a poly(A)-specific ribonuclease and the 5' cap influences mRNA deadenylation rates in vitro. Mol Cell 5:479-488. [ Links ]
Gao M, Wilusz CJ, Peltz SW and Wilusz J (2001) A novel mRNA-decapping activity in HeLa cytoplasmic extracts is regulated by AU-rich elements. EMBO J 20:1134-1143. [ Links ]
Garcia-Martinez J, Aranda A and Perez-Ortin JE (2004) Genomic run-on evaluates transcription rates for all yeast genes and identifies gene regulatory mechanisms. Mol Cell 15:303-313. [ Links ]
Garneau NL, Wilusz J and Wilusz C (2007) The highways and byways of mRNA decay. Nat Rev Cell Mol Biol in press. [ Links ]
Gautier-Courteille C, Le Clainche C, Barreau C, Audic Y, Graindorge A, Maniey D, Osborne HB and Paillard L (2004) EDEN-BP-dependent post-transcriptional regulation of gene expression in Xenopus somitic segmentation. Development 131:6107-6117. [ Links ]
Gherzi R, Lee KY, Briata P, Wegmuller D, Moroni C, Karin M and Chen CY (2004) A KH domain RNA binding protein, KSRP, promotes ARE-directed mRNA turnover by recruiting the degradation machinery. Mol Cell 14:571-583. [ Links ]
Guhaniyogi J and Brewer G (2001) Regulation of mRNA stability in mammalian cells. Gene 265:11-23. [ Links ]
Hughes TA and Brady HJ (2005) Axin2 expression is regulated by the alternative 5' untranslated regions of its mRNA. J Biol Chem 280:8581-8588. [ Links ]
Korner CG and Wahle E (1997) Poly(A) tail shortening by a mammalian poly(A)-specific 3'-exoribonuclease. J Biol Chem 272:10448-10456. [ Links ]
Korner CG, Wormington M, Muckenthaler M, Schneider S, Dehlin E and Wahle E (1998) The deadenylating nuclease (DAN) is involved in poly(A) tail removal during the meiotic maturation of Xenopus oocytes. EMBO J 17:5427-5437. [ Links ]
Lai WS, Kennington EA and Blackshear PJ (2003) Tristetraprolin and its family members can promote the cell-free deadenylation of AU-rich element-containing mRNAs by poly(A) ribonuclease. Mol Cell Biol 23:3798-3812. [ Links ]
Lejeune F, Li X and Maquat LE (2003) Nonsense-mediated mRNA decay in mammalian cells involves decapping, deadenylating, and exonucleolytic activities. Mol Cell 12:675-587. [ Links ]
Lemm I and Ross J (2002) Regulation of c-myc mRNA decay by translational pausing in a coding region instability determinant. Mol Cell Biol 22:3959-3969. [ Links ]
Lowell JE, Rudner DZ and Sachs AB (1992) 3'-UTR-dependent deadenylation by the yeast poly(A) nuclease. Genes Dev 6:2088-2099. [ Links ]
Martinez J, Ren YG, Nilsson P, Ehrenberg M and Virtanen A (2001) The mRNA cap structure stimulates rate of poly(A) removal and amplifies processivity of degradation. J Biol Chem 276:27923-27929. [ Links ]
Meyer S, Temme C and Wahle E (2004) Messenger RNA turnover in eukaryotes: Pathways and enzymes. Crit Rev Biochem Mol Biol 39:197-216. [ Links ]
Moraes KC, Wilusz CJ and Wilusz J (2006) CUG-BP binds to RNA substrates and recruits PARN deadenylase. RNA 12:1084-1091. [ Links ]
Mukherjee D, Gao M, O'Connor JP, Raijmakers R, Pruijn G, Lutz CS and Wilusz J (2002) The mammalian exosome mediates the efficient degradation of mRNAs that contain AU-rich elements. EMBO J 21:165-174. [ Links ]
Mukhopadhyay D, Houchen CW, Kennedy S, Dieckgraefe BK and Anant S (2003) Coupled mRNA stabilization and translational silencing of cyclooxygenase-2 by a novel RNA binding protein, CUGBP2. Mol Cell 11:113-126. [ Links ]
Paillard L, Legagneux V, Maniey D and Osborne HB (2002) c-Jun ARE targets mRNA deadenylation by an EDEN-BP (embryo deadenylation element-binding protein)-dependent pathway. J Biol Chem 277:3232-3235. [ Links ]
Paillard L, Legagneux V and Osborne HB (2003) A functional deadenylation assay identifies human CUG-BP as a deadenylation factor. Biol Cell 95:107-113. [ Links ]
Paillard L, Omilli F, Legagneux V, Bassez T, Maniey D and Osborne HB (1998) EDEN and EDEN-BP, a cis element and an associated factor that mediate sequence-specific mRNA deadenylation in Xenopus embryos. EMBO J 17:278-287. [ Links ]
Raghavan A, Dhalla M, Bakheet T, Ogilvie RL, Vlasova IA, Khabar KS, Williams BR and Bohjanen PR (2004) Patterns of coordinate down-regulation of ARE-containing transcripts following immune cell activation. Genomics 84:1002-1013. [ Links ]
Roberts R, Timchenko NA, Miller JW, Reddy S, Caskey CT, Swanson MS and Timchenko LT (1997) Altered phosphorylation and intracellular distribution of a (CUG)n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice. Proc Natl Acad Sci USA 94:13221-13226. [ Links ]
Takahashi N, Sasagawa N, Suzuki K and Ishiura S (2000) The CUG-binding protein binds specifically to UG dinucleotide repeats in a yeast three-hybrid system. Biochem Biophys Res Commun 277:518-523. [ Links ]
Temme C, Zaessinger S, Meyer S, Simonelig M and Wahle E (2004) A complex containing the CCR4 and CAF1 proteins is involved in mRNA deadenylation in Drosophila. EMBO J 23:2862-2871. [ Links ]
Timchenko LT, Timchenko NA, Caskey CT and Roberts R (1996) Novel proteins with binding specificity for DNA CTG repeats and RNA CUG repeats: Implications for myotonic dystrophy. Hum Mol Genet 5:115-121. [ Links ]
Tran H, Schilling M, Wirbelauer C, Hess D and Nagamine Y (2004) Facilitation of mRNA deadenylation and decay by the exosome-bound, DExH protein RHAU. Mol Cell 13:101-111. [ Links ]
Tucker M, Valencia-Sanchez MA, Staples RR, Chen J, Denis CL and Parker R (2001) The transcription factor associated CCR4 and Caf1 proteins are components of the major cytoplasmic mRNA deadenylase in Saccharomyces cerevisiae. Cell 104:377-386. [ Links ]
Uchida N, Hoshino S and Katada T (2004) Identification of a human cytoplasmic poly(A) nuclease complex stimulated by poly(A)-binding protein. J Biol Chem 279:1383-1391. [ Links ]
Viswanathan P, Chen J, Chiang YC and Denis CL (2003) Identification of multiple RNA features that influence CCR4 deadenylation activity. J Biol Chem 278:14949-14955. [ Links ]
Viswanathan P, Ohn T, Chiang YC, Chen J and Denis CL (2004) Mouse CAF1 can function as a processive deadenylase/3'-5'-exonuclease in vitro but in yeast the deadenylase function of CAF1 is not required for mRNA poly(A) removal. J Biol Chem 279:23988-23995. [ Links ]
Wilson T and Treisman R (1988) Removal of poly(A) and consequent degradation of c-fos mRNA facilitated by 3' AU-rich sequences. Nature 336:396-399. [ Links ]
Wilusz CJ and Wilusz J (2004) Bringing the role of mRNA decay in the control of gene expression into focus. Trends Genet 20:491-497. [ Links ]
Xu N, Chen CY and Shyu AB (1997) Modulation of the fate of cytoplasmic mRNA by AU-rich elements: Key sequence features controlling mRNA deadenylation and decay. Mol Cell Biol 17:4611-4621. [ Links ]
Yamashita A, Chang TC, Yamashita Y, Zhu W, Zhong Z, Chen CY and Shyu AB (2005) Concerted action of poly(A) nucleases and decapping enzyme in mammalian mRNA turnover. Nat Struct Mol Biol 12:1054-1063. [ Links ]
Send correspondence to:
Department of Microbiology
Immunology and Pathology
Colorado State University, 1682 Campus Delivery
80523-1682 Fort Collins, CO, USA
Received: January 25, 2007; Accepted: March 27, 2007.
Associate Editor: Carlos F.M. Menck
1 Current address: Universidade do Vale do Paraíba, IP&D, Av. Shishima Hifumi 2911, Urbanova, 12244-000, São José dos Campos, SP, Brazil.